16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23345.05 (-0.46)

S&P 5960.5 (0.26)

LOGIN HERE

companylogoMakers Laboratories Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 506919 | NSE Symbol : | ISIN : INE987A01010 | Industry : Pharmaceuticals - Indian - Formulations |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
14-Jan-2025 29-Jan-2025 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2024 of the financial year 2024-25. Standalone and Consolidated Q3FY25 Unaudited Financial Results (As per BSE Announcement Dated on 29/01/2025)
17-Oct-2024 29-Oct-2024 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 2nd quarter and half year ended 30th September 2024. Standalone and Consolidated Q2H1FY25 Results (As Per BSE Announcement dated on 29.10.2024)
22-Jul-2024 06-Aug-2024 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 1st quarter ended 30th June 2024 of the financial year 2024-25. Standalone and Consolidated Q1FY25 Results (As Per BSE Announcement Dated on 06.08.2024)
07-May-2024 23-May-2024 Accounts MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for the 4th quarter and financial year ended 31st March 2024 Outcome of Board Meeting (As per BSE Announcement Dated on 23/05/2024)
22-Jan-2024 13-Feb-2024 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Prior Intimation of the Board Meeting to be held on 13th February 2024 to consider and take on record Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ended 31st December 2023 for the FY 2023-24. Outcome of the Board Meeting held on 13.02.2024 Unaudited Standalone and Consolidated Financial Results for the quarter ended December 2023 (As Per BSE Announcement Dated on 13/02/2024)
19-Oct-2023 07-Nov-2023 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for Q2 and H1 FY24. Outcome of the Board Meeting held on 07.11.2023- Unaudited Financial Results for Q2 H1 FY24 (As Per BSE Announcement Dated on 07.11.2023)
25-Jul-2023 14-Aug-2023 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June 2023. MAKERS LABORATORIES LIMITED has informed BSE about Board Meeting to be held on 14 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Q1 FY 24 Standalone and Consolidated Results Unaudited Financial Results for the Quarter ended June 30, 2023. (As Per BSE Announcement Dated on 14.08.2023)
10-May-2023 22-May-2023 Accounts MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 inter alia to consider and approve Audited financial results for the 4th quarter and financial year ended 31st March 2023. Standalone and Consolidated Audited Results for FY23 (As Per BSE Announcement dated on 22.05.2023)
28-Apr-2023 28-Apr-2023 Change in Other Executives Outcome of the Board Meeting dated 28.04.2023 At the meeting of the Board of Directors of the Company held today, the Board has appointed Ms. Surbhi Sharma (ACS No. 66485) as the Company Secretary, Compliance Officer and Nodal Officer for IEPF of the Company w.e.f. 28.04.2023
20-Jan-2023 13-Feb-2023 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2022 of the financial year 2022-23. We are enclosing herewith our Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Auditors thereon for the 3rd Quarter and nine months ended 31st December,2022, which was taken on record at the Meeting of the Board of Directors of the Company held today at Kandivli, Mumbai. (As Per BSE Announcement Dated on 13.02.2023)
19-Oct-2022 14-Nov-2022 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 2nd Quarter and half year ended 30th September 2022 of the Financial Year 2022-23. We are enclosing herewith our Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Auditors thereon for the 2nd Quarter and half year ended 30th September, 2022, which was taken on record at the Meeting of the Board of Directors of the Company held today at Kandivli, Mumbai. We are enclosing herewith our Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Auditors thereon for the 2nd Quarter and half year ended 30th September, 2022, which was taken on record at the Meeting of the Board of Directors of the Company held today at Kandivli, Mumbai. (As Per BSE Announcement Dated on 14.11.2022)
29-Jul-2022 12-Aug-2022 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the 1st Quarter ended 30th June 2022 of the financial year 2022-23. Standalone and Consolidated Unaudited Financial Results for the 1st Quarter ended 30th June, 2022 of the financial year 2022-23 (As per BSE Announcement Dated on 12/08/2022)
17-May-2022 27-May-2022 Accounts MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 inter alia to consider and approve Audited Financial Results for the 4th Quarter and Financial Year ended 31st March 2022 Makers Q4 FY 2022 - Results Q4 FY 2022 Results (As per BSE Announcement Dated on 27/5/2022)
02-May-2022 06-May-2022 Right Issue Rights Issue MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2022 ,inter alia, to consider and approve This is to inform you that at a meeting of the Board of Directors of the Company will be held on Friday, 5th May, 2022, inter-alia to consider allotment of 9,83,396 equity shares of Rs. 10/- each @ Rs. 150/- per share, including a premium of Rs. 140/- per Share, under the Company's Rights Equity Issue, which closed for subscription on 27th April, 2022. This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has allotted 9,83,396 equity shares of Rs. 10/- each @ Rs. 150/- per share, including a premium of Rs. 140/- per share, under the Company's Rights Equity Issue, which closed for subscription on 27th April, 2022. (As Per BSE Announcement dated on 06.05.2022)
25-Jan-2022 09-Feb-2022 Quarterly Results MAKERS LABORATORIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve Unaudited Financial Results for the 3rd quarter and nine months ended 31st December 2021 of the financial year 2021-22. Unaudited Standalone & Consolidated Financial Results along with limited review reports of the Company''s Auditors thereon for the 3rd quarter and nine months ended 31st December, 2021 along with Limited review report thereon. (As per BSE Announcement Dated on 09/02/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +